Nitin J. Karandikar

7.3k total citations · 1 hit paper
116 papers, 5.6k citations indexed

About

Nitin J. Karandikar is a scholar working on Immunology, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Nitin J. Karandikar has authored 116 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Immunology, 39 papers in Pathology and Forensic Medicine and 25 papers in Hematology. Recurrent topics in Nitin J. Karandikar's work include T-cell and B-cell Immunology (49 papers), Immunotherapy and Immune Responses (40 papers) and Immune Cell Function and Interaction (30 papers). Nitin J. Karandikar is often cited by papers focused on T-cell and B-cell Immunology (49 papers), Immunotherapy and Immune Responses (40 papers) and Immune Cell Function and Interaction (30 papers). Nitin J. Karandikar collaborates with scholars based in United States, France and India. Nitin J. Karandikar's co-authors include Sterling Ortega, Stephen D. Miller, Carol L. Vanderlugt, Michael K. Racke, Daniel C. Douek, Richard A. Koup, Robert W. McKenna, Jason M. Brenchley, David R. Ambrozak and Vinodh Pillai and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Nitin J. Karandikar

115 papers receiving 5.5k citations

Hit Papers

Expression of CD57 defines replicative senescence and ant... 2003 2026 2010 2018 2003 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells
    2003 812 citations Nitin J. Karandikar et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nitin J. Karandikar United States 36 3.4k 1.4k 1.0k 803 539 116 5.6k
Jan D. Lünemann Germany 40 2.3k 0.7× 1.7k 1.2× 1.2k 1.2× 1.0k 1.3× 255 0.5× 127 5.5k
Jason G. Cyster United States 33 5.7k 1.7× 468 0.3× 2.1k 2.1× 1.5k 1.9× 248 0.5× 44 8.1k
John Schindler United States 32 2.3k 0.7× 545 0.4× 1.0k 1.0× 1.7k 2.1× 543 1.0× 56 4.3k
Maria Wiekowski United States 34 4.3k 1.3× 754 0.5× 1.3k 1.3× 1.8k 2.3× 597 1.1× 52 7.0k
Claire L. Langrish United States 12 4.7k 1.4× 1.0k 0.7× 677 0.7× 900 1.1× 490 0.9× 15 5.9k
Laurence Boumsell France 48 3.4k 1.0× 1.0k 0.7× 1.3k 1.3× 886 1.1× 433 0.8× 152 6.8k
Nathan Karin Israel 35 3.3k 1.0× 794 0.6× 1.0k 1.0× 1.7k 2.1× 220 0.4× 62 5.2k
Anton W. Langerak Netherlands 46 2.8k 0.8× 1.9k 1.4× 1.7k 1.6× 1.3k 1.6× 1.2k 2.2× 208 6.5k
Odile Devergne France 34 2.6k 0.8× 844 0.6× 517 0.5× 1.9k 2.3× 149 0.3× 62 4.4k
Shixin Qin United States 37 6.4k 1.9× 462 0.3× 1.2k 1.2× 2.9k 3.6× 415 0.8× 49 9.1k

Countries citing papers authored by Nitin J. Karandikar

Since Specialization
Citations

This map shows the geographic impact of Nitin J. Karandikar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nitin J. Karandikar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nitin J. Karandikar more than expected).

Fields of papers citing papers by Nitin J. Karandikar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nitin J. Karandikar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nitin J. Karandikar. The network helps show where Nitin J. Karandikar may publish in the future.

Co-authorship network of co-authors of Nitin J. Karandikar

This figure shows the co-authorship network connecting the top 25 collaborators of Nitin J. Karandikar. A scholar is included among the top collaborators of Nitin J. Karandikar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nitin J. Karandikar. Nitin J. Karandikar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chopra, Saurav, Nitin J. Karandikar, & Carol Holman. (2023). Systematic Evaluation of Hematologic Parameters and Blood Smear Findings in Patients With SARS-CoV-2 vs Other Viral Respiratory Infections. American Journal of Clinical Pathology. 160(4). 331–334. 1 indexed citations
3.
Farooqui, Mudassir, Santiago Ortega‐Gutiérrez, Vanessa O. Torres, et al.. (2022). Hyperacute immune responses associate with immediate neuropathology and motor dysfunction in large vessel occlusions. Annals of Clinical and Translational Neurology. 10(2). 276–291.
4.
Jensen, Isaac J., et al.. (2021). A Functionally Distinct CXCR3+/IFN-γ+/IL-10+ Subset Defines Disease-Suppressive Myelin-Specific CD8 T Cells. The Journal of Immunology. 206(6). 1151–1160. 5 indexed citations
5.
Roa, Jorge A., Mario Zanaty, Daizo Ishii, et al.. (2020). Preliminary results in the analysis of the immune response after aneurysmal subarachnoid hemorrhage. Scientific Reports. 10(1). 11809–11809. 29 indexed citations
6.
Karandikar, Nitin J., et al.. (2020). Immune Autoregulatory CD8 T Cells Require IFN-γ Responsiveness to Optimally Suppress Central Nervous System Autoimmunity. The Journal of Immunology. 205(2). 359–368. 5 indexed citations
7.
Zhao, Picheng, et al.. (2018). Presenilin1 regulates Th1 and Th17 effector responses but is not required for experimental autoimmune encephalomyelitis. PLoS ONE. 13(8). e0200752–e0200752. 5 indexed citations
8.
Tyler, Andrew, Jason P. Mendoza, Mihail Firan, & Nitin J. Karandikar. (2013). CD8+ T Cells Are Required For Glatiramer Acetate Therapy in Autoimmune Demyelinating Disease. PLoS ONE. 8(6). e66772–e66772. 30 indexed citations
9.
Firan, Mihail, et al.. (2011). Viral Interactions with B-Cells Contribute to Increased Regulatory T-Cells During Chronic HCV Infection. Viral Immunology. 24(2). 119–129. 9 indexed citations
10.
Tyler, Andrew, Jason P. Mendoza, Sterling Ortega, Mihail Firan, & Nitin J. Karandikar. (2011). CD8+ T-cells are required for the action of glatiramer acetate therapy for autoimmune demyelinating disease (164.19). The Journal of Immunology. 186(1_Supplement). 164.19–164.19. 1 indexed citations
11.
Baughman, Ethan, Jason P. Mendoza, Sterling Ortega, et al.. (2011). Neuroantigen-specific CD8+ regulatory T-cell function is deficient during acute exacerbation of multiple sclerosis. Journal of Autoimmunity. 36(2). 115–124. 67 indexed citations
12.
Tirado, Carlos A, Laura J. Klesse, Nitin J. Karandikar, et al.. (2010). Acute myeloid leukemia with inv(16) with CBFB–MYH11, 3′CBFB deletion, variant t(9;22) with BCR–ABL1, and del(7)(q22q32) in a pediatric patient: case report and literature review. Cancer Genetics and Cytogenetics. 200(1). 54–59. 17 indexed citations
13.
14.
Fuda, Franklin, Nitin J. Karandikar, & Weina Chen. (2009). Significant CD5 Expression on Normal Stage 3 Hematogones and Mature B Lymphocytes in Bone Marrow. American Journal of Clinical Pathology. 132(5). 733–737. 14 indexed citations
15.
Mehta, Riyaz, et al.. (2006). Therapeutic Induction of Regulatory, Cytotoxic CD8+ T Cells in Multiple Sclerosis. The Journal of Immunology. 176(11). 7119–7129. 173 indexed citations
16.
Xu, Yin, et al.. (2005). Flow Cytometric Analysis of Monocytes as a Tool for Distinguishing Chronic Myelomonocytic Leukemia From Reactive Monocytosis. American Journal of Clinical Pathology. 124(5). 799–806. 63 indexed citations
17.
Eagar, Todd N., Danielle M. Turley, Josette Padilla, et al.. (2004). CTLA-4 Regulates Expansion and Differentiation of Th1 Cells Following Induction of Peripheral T Cell Tolerance. The Journal of Immunology. 172(12). 7442–7450. 26 indexed citations
18.
Karandikar, Nitin J., Carol L. Vanderlugt, Todd N. Eagar, et al.. (1998). Tissue-Specific Up-Regulation of B7-1 Expression and Function During the Course of Murine Relapsing Experimental Autoimmune Encephalomyelitis. The Journal of Immunology. 161(1). 192–199. 57 indexed citations
19.
Karandikar, Nitin J., et al.. (1996). CTLA-4 blockade enhances t cell responses and exacerbates experimental autoimmune encephalomyelitis. The FASEB Journal. 10(6). 1 indexed citations
20.
Karandikar, Nitin J., Carol L. Vanderlugt, Theresa L. Walunas, Stephen D. Miller, & J A Bluestone. (1996). CTLA-4: a negative regulator of autoimmune disease.. The Journal of Experimental Medicine. 184(2). 783–788. 323 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jan D. Lünemann Breakdown of academic impact, for papers by Jason G. Cyster Breakdown of academic impact, for papers by John Schindler Breakdown of academic impact, for papers by Maria Wiekowski Breakdown of academic impact, for papers by Claire L. Langrish Breakdown of academic impact, for papers by Laurence Boumsell Breakdown of academic impact, for papers by Nathan Karin Breakdown of academic impact, for papers by Anton W. Langerak Breakdown of academic impact, for papers by Odile Devergne Breakdown of academic impact, for papers by Shixin Qin
Rankless by CCL
2026